©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 109414
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.109414
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.109414
Table 2 Partial correlation between C-peptide and hemoglobin A1c
| r value | 95%CI | P value | |
| FCP | -0.168 | -0.249 to -0.075 | < 0.001 |
| 2hCP | -0.423 | -0.480 to -0.362 | < 0.001 |
| Delta CP | -0.445 | -0.503 to -0.388 | < 0.001 |
| CP ratio | -0.057 | -0.309 to -0.008 | 0.23 |
| FCP/ fasting plasma glucose | -0.346 | -0.415 to -0.273 | < 0.001 |
| 2hCP/postprandial blood glucose | -0.485 | -0.551 to -0.414 | < 0.001 |
| Delta CP/BG | -0.428 | -0.501 to -0.351 | < 0.001 |
| CP/BG ratio | -0.058 | -0.320 to -0.048 | 0.222 |
- Citation: Wang Z, Deng MQ, Guo LX, Pan Q. Postprandial C-peptide is more relevant to hemoglobin A1c levels and diabetic microvascular complications than fasting C-peptide in type 2 diabetes. World J Diabetes 2025; 16(9): 109414
- URL: https://www.wjgnet.com/1948-9358/full/v16/i9/109414.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i9.109414